Literature DB >> 22690262

A Patient With Metastatic Adenocarcinoma of the Jejunum Who Had a Prolonged Complete Response to FOLFOX.

Sueyi Lai, William Leslie.   

Abstract

Entities:  

Year:  2012        PMID： 22690262      PMCID： PMC3369595     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  11 in total

Review 1.  Anatomical and physiological parameters affecting gastrointestinal absorption in humans and rats.

Authors:  J M DeSesso; C F Jacobson
Journal:  Food Chem Toxicol       Date:  2001-03       Impact factor: 6.023

2.  Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases.

Authors:  Paula N Fishman; Gregory R Pond; Malcolm J Moore; Amit Oza; Ronald L Burkes; Lillian L Siu; Ronald Feld; Steven Gallinger; Paul Greig; Jennifer J Knox
Journal:  Am J Clin Oncol       Date:  2006-06       Impact factor: 2.339

3.  Combination chemotherapy in advanced small bowel adenocarcinoma.

Authors:  Christophe Locher; David Malka; Valérie Boige; Pascal Lebray; Dominique Elias; Philippe Lasser; Michel Ducreux
Journal:  Oncology       Date:  2005-11-09       Impact factor: 2.935

4.  Chemotherapy of advanced small-bowel adenocarcinoma: a multicenter AGEO study.

Authors:  A Zaanan; L Costes; M Gauthier; D Malka; C Locher; E Mitry; D Tougeron; T Lecomte; J-M Gornet; I Sobhani; V Moulin; P Afchain; J Taïeb; F Bonnetain; T Aparicio
Journal:  Ann Oncol       Date:  2010-03-11       Impact factor: 32.976

5.  Chemotherapy in small bowel adenocarcinoma: 10-year experience of the British Columbia Cancer Agency.

Authors:  P Czaykowski; D Hui
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-03       Impact factor: 4.126

6.  Chemotherapy for primary adenocarcinoma of the small bowel.

Authors:  D Jigyasu; A Y Bedikian; J R Stroehlein
Journal:  Cancer       Date:  1984-01-01       Impact factor: 6.860

7.  Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.

Authors:  Bouthaina S Dabaja; Dima Suki; Barbara Pro; Mark Bonnen; Jaffer Ajani
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

8.  Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years.

Authors:  Karl Y Bilimoria; David J Bentrem; Jeffrey D Wayne; Clifford Y Ko; Charles L Bennett; Mark S Talamonti
Journal:  Ann Surg       Date:  2009-01       Impact factor: 12.969

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

10.  Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.

Authors:  Michael J Overman; Gauri R Varadhachary; Scott Kopetz; Rosni Adinin; E Lin; Jeffrey S Morris; Cathy Eng; James L Abbruzzese; Robert A Wolff
Journal:  J Clin Oncol       Date:  2009-01-21       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.